Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.029 | 0.9 |
mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |